BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26881923)

  • 1. The BCL2 -938C>A Promoter Polymorphism Is Associated with Risk for and Time to Aseptic Loosening of Total Hip Arthroplasty.
    Stelmach P; Wedemeyer C; Fuest L; Kurscheid G; Gehrke T; Klenke S; Jäger M; Kauther MD; Bachmann HS
    PLoS One; 2016; 11(2):e0149528. PubMed ID: 26881923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCL2-938C>A and CALCA-1786T>C polymorphisms in aseptic loosened total hip arthroplasty.
    Wedemeyer C; Kauther MD; Hanenkamp S; Nückel H; Bau M; Siffert W; Bachmann HS
    Eur J Med Res; 2009 Jun; 14(6):250-5. PubMed ID: 19541585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender-dependent association of the GNAS1 T393C polymorphism with early aseptic loosening after total hip arthroplasty.
    Bachmann HS; Hanenkamp S; Kornacki B; Frey UH; Bau M; Siffert W; Wedemeyer C
    J Orthop Res; 2008 Dec; 26(12):1562-8. PubMed ID: 18634020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single nucleotide polymorphisms in the interleukin-6 gene promoter, tumor necrosis factor-alpha gene promoter, and transforming growth factor-beta1 gene signal sequence as predictors of time to onset of aseptic loosening after total hip arthroplasty: preliminary study.
    Kolundzić R; Orlić D; Trkulja V; Pavelić K; Troselj KG
    J Orthop Sci; 2006 Nov; 11(6):592-600. PubMed ID: 17139467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between GNAS1 T393C polymorphism and aseptic loosening after total hip arthroplasty.
    Stelmach P; Kauther MD; Fuest L; Kurscheid G; Gehrke T; Klenke S; Jäger M; Wedemeyer C; Bachmann HS
    Eur J Med Res; 2017 Aug; 22(1):29. PubMed ID: 28830502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic susceptibility to aseptic loosening following total hip arthroplasty: a systematic review.
    Del Buono A; Denaro V; Maffulli N
    Br Med Bull; 2012; 101():39-55. PubMed ID: 21652593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic susceptibility of early aseptic loosening after total hip arthroplasty: the influence of TIMP-1 gene polymorphism on Chinese Han population.
    Pan F; Hua S; Luo Y; Yin D; Ma Z
    J Orthop Surg Res; 2014 Dec; 9():108. PubMed ID: 25466591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No Association of CALCA Polymorphisms and Aseptic Loosening after Primary Total Hip Arthroplasty.
    Aydin-Yüce T; Kurscheid G; Bachmann HS; Gehrke T; Dudda M; Jäger M; Wedemeyer C; Kauther MD
    Biomed Res Int; 2018; 2018():3687415. PubMed ID: 29967770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity Is Independently Associated With Early Aseptic Loosening in Primary Total Hip Arthroplasty.
    Goodnough LH; Finlay AK; Huddleston JI; Goodman SB; Maloney WJ; Amanatullah DF
    J Arthroplasty; 2018 Mar; 33(3):882-886. PubMed ID: 29089226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes Mellitus and Hyperglycemia and the Risk of Aseptic Loosening in Total Joint Arthroplasty.
    Maradit Kremers H; Schleck CD; Lewallen EA; Larson DR; Van Wijnen AJ; Lewallen DG
    J Arthroplasty; 2017 Sep; 32(9S):S251-S253. PubMed ID: 28343827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic susceptibility to total hip arthroplasty failure: a case-control study on the influence of MMP 1 gene polymorphism.
    Yan Y; Hu J; Lu H; Wang W
    Diagn Pathol; 2014 Sep; 9():177. PubMed ID: 25257555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What Host Factors Affect Aseptic Loosening After THA and TKA?
    Cherian JJ; Jauregui JJ; Banerjee S; Pierce T; Mont MA
    Clin Orthop Relat Res; 2015 Aug; 473(8):2700-9. PubMed ID: 25716213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of BCL2-938 C>A promoter polymorphism and BCL2 gene expression on the progression of breast cancer.
    Bhushann Meka P; Jarjapu S; Vishwakarma SK; Nanchari SR; Cingeetham A; Annamaneni S; Mukta S; Triveni B; Satti V
    Tumour Biol; 2016 May; 37(5):6905-12. PubMed ID: 26662799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trabecular Metal Acetabular Components Reduce the Risk of Revision Following Primary Total Hip Arthroplasty: A Propensity Score Matched Study From the National Joint Registry for England and Wales.
    Matharu GS; Judge A; Murray DW; Pandit HG
    J Arthroplasty; 2018 Feb; 33(2):447-452. PubMed ID: 28947370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of hereditary hemochromatosis in aseptic loosening following primary total hip arthroplasty.
    Lunn JV; Gallagher PM; Hegarty S; Kaliszer M; Crowe J; Murray P; Bouchier-Hayes D
    J Orthop Res; 2005 May; 23(3):542-8. PubMed ID: 15885473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity is Associated With Early Total Hip Revision for Aseptic Loosening.
    Electricwala AJ; Narkbunnam R; Huddleston JI; Maloney WJ; Goodman SB; Amanatullah DF
    J Arthroplasty; 2016 Sep; 31(9 Suppl):217-20. PubMed ID: 27108056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional variants of the P2RX7 gene, aseptic osteolysis, and revision of the total hip arthroplasty: a preliminary study.
    Mrazek F; Gallo J; Stahelova A; Petrek M
    Hum Immunol; 2010 Feb; 71(2):201-5. PubMed ID: 19891999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the CC genotype of the regulatory BCL2 promoter polymorphism (-938C>A) with better 2-year survival in patients with glioblastoma multiforme.
    El Hindy N; Bachmann HS; Lambertz N; Adamzik M; Nückel H; Worm K; Zhu Y; Sure U; Siffert W; Sandalcioglu IE
    J Neurosurg; 2011 Jun; 114(6):1631-9. PubMed ID: 21250804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometry as a diagnostic tool for identifying total hip arthroplasty loosening and differentiating between septic and aseptic cases.
    Ovrenovits M; Pakos EE; Vartholomatos G; Paschos NK; Xenakis TA; Mitsionis GI
    Eur J Orthop Surg Traumatol; 2015 Oct; 25(7):1153-9. PubMed ID: 26163007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The AA genotype of the regulatory BCL2 promoter polymorphism ( 938C>A) is associated with a favorable outcome in lymph node negative invasive breast cancer patients.
    Bachmann HS; Otterbach F; Callies R; Nückel H; Bau M; Schmid KW; Siffert W; Kimmig R
    Clin Cancer Res; 2007 Oct; 13(19):5790-7. PubMed ID: 17908970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.